• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 相关心脏问题:全面综述。

Cardiac Involvement of COVID-19: A Comprehensive Review.

机构信息

Division of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan.

Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan.

出版信息

Am J Med Sci. 2021 Jan;361(1):14-22. doi: 10.1016/j.amjms.2020.10.002. Epub 2020 Oct 6.

DOI:10.1016/j.amjms.2020.10.002
PMID:33187633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7536131/
Abstract

Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2 caused COVID-19 has reached a pandemic level. COVID-19 can significantly affect patients' cardiovascular systems. First, those with COVID-19 and preexisting cardiovascular disease have an increased risk of severe disease and death. Mortality from COVID-19 is strongly associated with cardiovascular disease, diabetes, and hypertension. Second, therapies under investigation for COVID-19 may have cardiovascular side effects of arrhythmia. Third, COVID-19 is associated with multiple direct and indirect cardiovascular complications. Associated with a high inflammatory burden related to cytokine release, COVID-19 can induce vascular inflammation, acute myocardial injury, myocarditis, arrhythmias, venous thromboembolism, metabolic syndrome and Kawasaki disease. Understanding the effects of COVID-19 on the cardiovascular system is essential for providing comprehensive medical care for cardiac and/or COVID-19 patients. We hereby review the literature on COVID-19 regarding cardiovascular virus involvement.

摘要

新型冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)病毒引起的传染病。SARS-CoV-2 引起的 COVID-19 已达到大流行水平。COVID-19 可显著影响患者的心血管系统。首先,患有 COVID-19 和既有心血管疾病的患者患重病和死亡的风险增加。COVID-19 的死亡率与心血管疾病、糖尿病和高血压密切相关。其次,正在研究用于治疗 COVID-19 的方法可能具有心律失常的心血管副作用。第三,COVID-19 与多种直接和间接的心血管并发症相关。与与细胞因子释放相关的高炎症负担相关,COVID-19 可引起血管炎症、急性心肌损伤、心肌炎、心律失常、静脉血栓栓塞、代谢综合征和川崎病。了解 COVID-19 对心血管系统的影响对于为心脏和/或 COVID-19 患者提供全面的医疗保健至关重要。在此,我们回顾了 COVID-19 相关心血管病毒感染的文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af0/7536131/3b16a5d6ddb8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af0/7536131/928a4bc3570d/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af0/7536131/3b16a5d6ddb8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af0/7536131/928a4bc3570d/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af0/7536131/3b16a5d6ddb8/gr1_lrg.jpg

相似文献

1
Cardiac Involvement of COVID-19: A Comprehensive Review.COVID-19 相关心脏问题:全面综述。
Am J Med Sci. 2021 Jan;361(1):14-22. doi: 10.1016/j.amjms.2020.10.002. Epub 2020 Oct 6.
2
Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports.新型冠状病毒肺炎对心血管系统的影响:现有报告综述。
Cardiovasc Drugs Ther. 2021 Jun;35(3):411-425. doi: 10.1007/s10557-020-07073-y. Epub 2020 Sep 14.
3
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.急性 COVID-19 心血管综合征的描述与处理建议。
Circulation. 2020 Jun 9;141(23):1903-1914. doi: 10.1161/CIRCULATIONAHA.120.047349. Epub 2020 Apr 16.
4
Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment.COVID-19 患者的心血管疾病:从心血管病理学到治疗的证据。
Acta Biochim Biophys Sin (Shanghai). 2021 Mar 2;53(3):273-282. doi: 10.1093/abbs/gmaa176.
5
A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.SARS-CoV-2 诱导的神经炎症、神经发育并发症综述,以及疫苗研发的最新进展。
Mol Neurobiol. 2021 Sep;58(9):4535-4563. doi: 10.1007/s12035-021-02399-6. Epub 2021 Jun 5.
6
"When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review.SARS-CoV-2 感染的“何时”“何地”和“如何”影响人体心血管系统:叙述性综述。
Balkan Med J. 2024 Jan 3;41(1):7-22. doi: 10.4274/balkanmedj.galenos.2023.2023-10-25.
7
Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.与 COVID-19 相关的心血管并发症及潜在治疗策略。
Int J Mol Sci. 2020 Sep 16;21(18):6790. doi: 10.3390/ijms21186790.
8
COVID-19 and the cardiovascular system: insights into effects and treatments.新型冠状病毒肺炎与心血管系统:对作用机制与治疗方法的深入了解
Can J Physiol Pharmacol. 2021 Nov;99(11):1119-1127. doi: 10.1139/cjpp-2021-0093. Epub 2021 Sep 21.
9
Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.α-硫辛酸对抗 COVID-19 感染期间心血管疾病的作用机制。
Int J Mol Sci. 2021 Jul 26;22(15):7979. doi: 10.3390/ijms22157979.
10
Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.肾素-血管紧张素-醛固酮系统和激肽-缓激肽系统在 COVID-19 和长新冠心血管并发症中的作用。
Int J Mol Sci. 2021 Jul 31;22(15):8255. doi: 10.3390/ijms22158255.

引用本文的文献

1
Impact of High Troponin Level on the Outcome in COVID-19 Positive Patients.高肌钙蛋白水平对新冠病毒检测呈阳性患者预后的影响。
J Multidiscip Healthc. 2024 Nov 1;17:4989-5000. doi: 10.2147/JMDH.S489622. eCollection 2024.
2
Impact of the COVID-19 pandemic on initiation of antihypertensive drugs in Sweden: an interrupted time series study.COVID-19 大流行对瑞典开始使用抗高血压药物的影响:一项中断时间序列研究。
BMJ Open. 2024 Oct 16;14(10):e082209. doi: 10.1136/bmjopen-2023-082209.
3
Alterations in plasma proteome during acute COVID-19 and recovery.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?儿童新冠病毒肺炎与高炎症综合征:伪装成巨噬细胞活化综合征的川崎病?
Cureus. 2020 Aug 1;12(8):e9515. doi: 10.7759/cureus.9515.
3
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
急性 COVID-19 及康复期间血浆蛋白质组的变化。
Mol Med. 2024 Aug 25;30(1):131. doi: 10.1186/s10020-024-00898-5.
4
Clinical utility of ambulatory ECG monitoring and 2D-ventricular strain for evaluation of post-COVID-19 ventricular arrhythmia.动态心电图监测和二维心室应变在评估新冠病毒后室性心律失常中的临床应用。
BMC Cardiovasc Disord. 2024 Aug 16;24(1):429. doi: 10.1186/s12872-024-03982-0.
5
COVID-19 and the risk of acute cardiovascular diseases: a two-sample Mendelian randomization study.COVID-19 与急性心血管疾病风险:两样本孟德尔随机研究。
BMC Cardiovasc Disord. 2024 Jul 27;24(1):389. doi: 10.1186/s12872-024-04066-9.
6
Acute Myocardial Infarction in COVID-19 Patients-A Review of Literature Data and Two-Case Report Series.COVID-19患者的急性心肌梗死——文献数据综述与两例病例报告系列
J Clin Med. 2024 May 16;13(10):2936. doi: 10.3390/jcm13102936.
7
Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart.病毒诱导的急性呼吸窘迫综合征通过在心脏中引发炎症反应引起心肌病。
Circulation. 2024 Jul 2;150(1):49-61. doi: 10.1161/CIRCULATIONAHA.123.066433. Epub 2024 Mar 20.
8
Cardiovascular Complications of COVID-19: A Scoping Review of Evidence.新型冠状病毒肺炎的心血管并发症:证据的范围综述
Cureus. 2023 Nov 4;15(11):e48275. doi: 10.7759/cureus.48275. eCollection 2023 Nov.
9
Lower ventricular and atrial strain in patients who recovered from COVID-19 assessed by cardiovascular magnetic resonance feature tracking.通过心血管磁共振特征追踪评估的COVID-19康复患者的心室和心房应变降低。
Front Cardiovasc Med. 2023 Nov 13;10:1293105. doi: 10.3389/fcvm.2023.1293105. eCollection 2023.
10
Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response.应对新冠疫情后的免疫时代:了解新冠长期症状与免疫反应
Life (Basel). 2023 Oct 26;13(11):2121. doi: 10.3390/life13112121.
瑞德西韦对比标准治疗对 11 天内中症 COVID-19 患者临床状态的影响:一项随机临床试验。
JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.
4
COVID-19 and multisystem inflammatory syndrome in children and adolescents.儿童和青少年的 COVID-19 和多系统炎症综合征。
Lancet Infect Dis. 2020 Nov;20(11):e276-e288. doi: 10.1016/S1473-3099(20)30651-4. Epub 2020 Aug 17.
5
Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach.儿童严重急性呼吸综合征冠状病毒 2 相关多系统炎症综合征的心脏表现:全面综述及拟议临床处理方法
Eur J Pediatr. 2021 Feb;180(2):307-322. doi: 10.1007/s00431-020-03766-6. Epub 2020 Aug 15.
6
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
7
Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint.新冠疫情:随着“康复”试验发布预印本,地塞米松需求激增。
BMJ. 2020 Jun 23;369:m2512. doi: 10.1136/bmj.m2512.
8
Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.检测心肌活检中的病毒 SARS-CoV-2 基因组和组织病理学变化。
ESC Heart Fail. 2020 Oct;7(5):2440-2447. doi: 10.1002/ehf2.12805. Epub 2020 Jun 12.
9
SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.引起 COVID-19 的 SARS-CoV-2 可导致儿童川崎病:促炎和抗炎细胞因子的作用。
J Biol Regul Homeost Agents. 2020;34(3):767-773. doi: 10.23812/EDITORIAL-RONCONI-E-59.
10
Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study.新型冠状病毒肺炎的心脏表现谱:一项系统超声心动图研究。
Circulation. 2020 Jul 28;142(4):342-353. doi: 10.1161/CIRCULATIONAHA.120.047971. Epub 2020 May 29.